Authors


Uzma Syed, DO, FIDSA

Latest:

Respiratory Virus Season: Colds and COVID-19 Update

Will this winter bring the feared twindemic of SARS-CoV-2 and influenza, or will another common infection reemerge?


Sean Van Helden, PharmD

Latest:

Expanding the Antibiotic Stewardship Team Can Lead to Greater Adoption of Practices

There is value in leveraging the contributions of nurses, laboratorians, and informaticists in antimicrobial stewardship.


Chad Costley, MD, MBA

Latest:

The NanoVax Vaccine Platform: Pandemic Preparedness and the Role of Mucosal Immunity

Chad Costley, MD, MPH, discussed the platform's ability to respond to emerging respiratory diseases and the challenges in advancing mucosal vaccine development for health preparedness.


Colleen Kelley, MD, MPH

Latest:

HIV Prevention: Discussing PrEP, PEP, and Vaccine Development

Colleen Kelley, MD, MPH, offers some insights on where we are today with the state of HIV prevention including the expanding PrEP options, why PEP is underutilized, and the challenges behind HIV vaccine development.


Kelly R. Reveles, PharmD, PhD, BCPS

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Ngofeen Mputubwele

Latest:

A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.


Mira Maximos, PharmD, MSc, ACPR

Latest:

The 5 Topics Every Infectious Disease Learner Should Read About, At Least Once!

In the latest Bench to Bedside column, clinicians provide information and resources on recommended topics learners should explore.


Deanna J. Buehrle, PharmD

Latest:

Bacterial Coinfections Among US Patients With Coronavirus Disease 2019

Implications for antimicrobial use and antimicrobial resistance.


Raneem H. Pallotta, PharmD

Latest:

NDM-Producing E coli Harboring PBP Insert Variants Emerges as New Threat

As with other metallo-β-lactamases, NDM is capable of hydrolyzing nearly all β-lactams, including carbapenems, and the search for the proper antimicrobials is challenging.


Kevin Nguyen, PharmD, BCIDP

Latest:

Addressing Neonatal CNS Infections: Case Report of Ceftaroline Therapy in Preterm Infant With Ventriculosubgaleal Shunt

Here is a novel use of ceftaroline to treat methicillin-resistant Staphylococcus epidermidis ventriculitis in a preterm infant with a ventriculosubgaleal shunt.


Ibram Mikhail, PharmD

Latest:

Addressing Neonatal CNS Infections: Case Report of Ceftaroline Therapy in Preterm Infant With Ventriculosubgaleal Shunt

Here is a novel use of ceftaroline to treat methicillin-resistant Staphylococcus epidermidis ventriculitis in a preterm infant with a ventriculosubgaleal shunt.


Sarah Rowan, MD

Latest:

Simplified Hepatitis C Protocols Raise Treatment Uptake and Cure Rates

Sarah Rowan, MD, on minimal laboratory testing, Hepatitis B screening flexibility, peer navigation, and state‑specific strategies to overcome outreach and reimbursement hurdles


Robbie Lee Anne Christian, Pharm.D., BCIDP, AAHIVP

Latest:

Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.



Catherine DeVoe, MD, and Peter Chin-Hong, MD

Latest:

Varicella Zoster Virus and Human Papillomavirus Vaccination in Immunocompromised Patients

Vaccination for VZV and HPV requires special consideration in immunocompromised patients. They are at risk for more severe viral illnesses if not immune, but they may also have decreased response to, and increased adverse effects from, vaccines.


Karen Tan, PharmD, BCIDP

Latest:

Optimizing Vancomycin Therapy: A Review of AUC Calculation Techniques

The ideal parameter for vancomycin monitoring is the area under the curve, which can be calculated using pharmacokinetic equations or Bayesian software.


Issac Smith

Latest:

Antimicrobial Stewardship in the Era of Multidrug-Resistant Infections

Here are some strategies to consider for optimal utilization.


Richelle L. Guerrero-Wooley, MD

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.



Abdulwhab Shremo Msdi, PharmD

Latest:

Estimating the AUC for Vancomycin Using Non Trapezoidal Equations

In the second part of our conversation, Abdulwhab Shremo Msdi, PharmD, discusses using this methodology.


Erlinda Ulloa, MD

Latest:

Phage, Combination Antibiotic Treatment For Resistant Pseudomonas aeruginosa Infection

Erlinda Ulloa, MD, discusses a severe case including how they secured the phage treatment, and her experience with the investigational therapy.


Rajeev Shah, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Brandon Anderson, PharmD

Latest:

PEN-FAST Forward: Accelerating Penicillin Allergy De-Labeling

PEN-FAST is a validated risk stratification tool that promotes efficient, safe, and effective de-labeling of penicillin allergies.


Bo Ram Keum, PharmD candidate

Latest:

Safety of Cefazolin Has Been Underestimated for GBS Prophylaxis During Labor

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).




Ashraf S Ibrahim, PhD

Latest:

Rising Mucormycosis Cases Drive Efforts for Spotlight on Treatment Research

Ashraf S. Ibrahim, PhD, outlines safety studies and the potential of this antibody therapy for treating this rare fungal infection, which is seemingly becoming less rare.


Renata O. Smith, PharmD, AAHIVP

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.


Kirby An, PharmD

Latest:

Trends in Carbapenemase-Producing Organisms: Prevalence, Treatment, and Outcomes

A study of carbapenemase-producing organisms found similar rates of infections, highlighting treatment challenges, the role of rapid diagnostics, and surveillance on antimicrobial stewardship due to high mortality rates.


Kari A. Mergenhagen, PHARMD, BCPS, BCIDP

Latest:

Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.

© 2025 MJH Life Sciences

All rights reserved.